Life-Sciences eQMS 12 items
Dissolution Testing Program Checklist (USP <711>)
Verifies that dissolution testing for oral and other dosage forms is properly developed, validated, qualified, and executed to assess drug release performance. Use to establish or audit a dissolution testing program.
USP <711>USP <1092>USP <711> Apparatus21 CFR 211.165
Free PDF · enter your email to download.
Method Development and Validation
Establish a discriminating method.
- Is the dissolution method developed to be discriminating for relevant formulation and process changes? *
- Are media, volume, and sink conditions selected and justified for the drug solubility? *
- Is the method validated for specificity, linearity, accuracy, and precision? *
- Select the dissolution apparatus type used.
Apparatus Qualification
- Is the dissolution apparatus mechanically qualified for parameters such as shaft wobble, vessel centering, and rotation speed? *
- Is performance verification testing (PVT) or an enhanced mechanical calibration performed at the required frequency? *
- Are media temperature (typically 37 +/- 0.5 C) and deaeration controlled? *
Acceptance Criteria and Testing
- Are staged acceptance criteria (S1, S2, S3) applied for the tolerance (Q value)? *
- Is the Q value and time point established and included in the release specification? *
- Record the specified Q value (%) for the product.
Data Review and Investigation
- Are dissolution results reviewed by the quality unit and any failures investigated? *
- Are profile comparisons (e.g., f2 similarity factor) used to support changes where applicable?
Download the full Dissolution Testing Program Checklist (USP <711>) checklist
Get it as a clean, printable PDF — free.
